Trinity Biotech PLC
NASDAQ:TRIB
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.09
3.46
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Trinity Biotech PLC
Trinity Biotech PLC
Cash Interest Paid
Trinity Biotech PLC
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Trinity Biotech PLC
NASDAQ:TRIB
|
Cash Interest Paid
$7.1m
|
CAGR 3-Years
21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Medtronic PLC
NYSE:MDT
|
Cash Interest Paid
$861m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
8%
|
|
|
STERIS plc
NYSE:STE
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Trinity Biotech PLC
Glance View
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.
See Also
What is Trinity Biotech PLC's Cash Interest Paid?
Cash Interest Paid
7.1m
USD
Based on the financial report for Jun 30, 2024, Trinity Biotech PLC's Cash Interest Paid amounts to 7.1m USD.
What is Trinity Biotech PLC's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
11%
Over the last year, the Cash Interest Paid growth was -5%. The average annual Cash Interest Paid growth rates for Trinity Biotech PLC have been 21% over the past three years , 11% over the past five years .
You don't have any saved screeners yet
